PPCB
Propanc Biopharma·NASDAQ
--
--(--)
--
--(--)
1.00 / 10
Underperform
Technical analysis reveals a poor setup with a score of 1.0/10. Dominant bearish signals include frequent long lower shadows, long upper shadows, and a MACD golden cross, all historically associated with negative returns. No bullish indicators are present, leading to a cautious technical outlook.
Analysis Checks(0/3)
Long Lower Shadow
Score1/10
Win Rate23.81%
Hist. Signals42
Avg Return-5.60%
Score1/10
Win Rate23.81%
Hist. Signals42
Avg Return-5.60%
MACD Golden Cross
Score1/10
Win Rate33.33%
Hist. Signals3
Avg Return-4.48%
Score1/10
Win Rate33.33%
Hist. Signals3
Avg Return-4.48%
Long Upper Shadow
Score1/10
Win Rate25.71%
Hist. Signals35
Avg Return-7.30%
Score1/10
Win Rate25.71%
Hist. Signals35
Avg Return-7.30%
Long Lower Shadow
Score1/10
Win Rate23.81%
Hist. Signals42
Avg Return-5.60%
Score1/10
Win Rate23.81%
Hist. Signals42
Avg Return-5.60%
Long Upper Shadow
Score1/10
Win Rate25.71%
Hist. Signals35
Avg Return-7.30%
Score1/10
Win Rate25.71%
Hist. Signals35
Avg Return-7.30%
MACD Golden Cross
Score1/10
Win Rate33.33%
Hist. Signals3
Avg Return-4.48%
Score1/10
Win Rate33.33%
Hist. Signals3
Avg Return-4.48%
Technical Analysis of PPCB?
- PPCB presents a Underperform setup with a Technical Score of 1.00/10. Key technical indicators highlight an RSI of 26.34 and a MACD of 0.01, with the trend anchored by the 50-Day SMA at 0.55. Traders should monitor key support at 0.16 and resistance at 0.23.
